Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Twist Bioscience Corp (NQ: TWST ) 48.00 +0.68 (+1.44%) Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Twist Bioscience Corp < Previous 1 2 3 4 5 6 7 8 9 Next > Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor June 06, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety June 04, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Corp. (NASDAQ: TWST) Near the Top of Equities by Percentage Gain on 11/17 November 17, 2023 Via Investor Brand Network Twist Bioscience to Present at Upcoming Investor Conferences May 23, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications May 13, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 08, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results May 02, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024 April 18, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations March 28, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing March 05, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at Upcoming Investor Conferences February 22, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) February 07, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System February 06, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications February 06, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT February 05, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results February 02, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Expands Express Genes Rapid Synthesis Service January 24, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024 January 16, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) January 08, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Appoints Adam Laponis as Chief Financial Officer January 05, 2024 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference December 18, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results November 17, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service November 14, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference November 13, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) November 08, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023 November 02, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing October 31, 2023 From Twist Bioscience Corporation Via Business Wire TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm October 05, 2023 From Bragar Eagel & Squire Via GlobeNewswire Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million October 05, 2023 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations October 03, 2023 From Twist Bioscience Corporation Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.